CSL Limited
CSL Limited (CSLLY) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · CSLLY · as of Jun 8, 2026
Key Statistics
Explore CSL Limited Data
cslly stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
cslly competitorsCSLLY
ARGNF
CHGCF
CHGCY
GLAXF
GNMSFStock Performance
Full HistoryAbout CSL Limited
CSL Limited is a global biopharmaceutical enterprise dedicated to the research, development, production, marketing, and distribution of a wide array of biopharmaceutical and related healthcare product…
what is csl limited · cslly stock overview · csl limited company profile · who is csl limited ceo · cslly OTC · csl limited headquarters · csl limited business segments
About Stock Overview & Key Data
CSL Limited (CSLLY) is a Healthcare company in the Biotechnology industry, listed on OTC since Dec 29, 2009. As of the latest trading session, CSLLY stock price is $17.12, with a market capitalization of $66.3B. The stock has returned -56.84% over the past 12 months and -40.56% year-to-date.
In fiscal year 2025, CSL Limited reported revenue of $15.4B. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, CSL Limited (CSLLY) stock price is $17.12. The stock is traded on OTC under the ticker symbol CSLLY. The 52-week range is $16.29 – $44.85.